Our research program ranks second nationally among all urology departments for National Institutes of Health funding, with amounts totaling more than $6.8 million. Our multi-dimensional, interactive and highly transformative approach to research provides the foundation for the department's strong research standing.
Conducting research to help advance men’s health in the fields of male reproductive medicine, sexual medicine and surgery.
Conducting research to improve the management and outcomes of patients born with congenital anomalies of the genitourinary system.
Evaluating techniques in robotic surgery and interventions to reduce kidney stone formation and recurrence.
Conducting research to eliminate the racial disparity in prostate cancer outcomes.
Studying care delivery and quality of care for urologic patients.
Developing new agents and interventions to improve outcomes and quality of life for patients with chronic pelvic pain and benign urologic conditions.
Developing the next generation of diagnostic and therapeutic nanoparticles.
Performing basic science and clinical research to improve the treatment and outcomes for children with urologic conditions.
Studying molecular, genetic and environmental contributors to prostate cancer to improve prostate cancer prevention, diagnosis and treatment.
Establishing new urologic tissue reconstruction models and developing treatment strategies for inflammation-based urologic conditions.
Conducting breakthrough research in genitourinary malignancies to develop novel therapeutics for bladder and kidney cancers.
Clinical trials test or study drugs, surgical procedures, medical devices or interventions with human subjects. Read more about our actively recruiting clinical trials.
Our department wants to support our investigators in their efforts by making sure they’re updated on all of our policies for conducting responsible research and the many resources available to them.
Dr. Cohen is interested in applying data science to medicine. He is currently working with Dr. Anthony Schaeffer to predict antibiotic resistance in women with UTIs. He also has research interests in prostate cancer and care for veterans.
Dr. Manjunath is working with Dr. Jason Wertheim to develop bioartificial kidney scaffolds for implantation into rodents, with the ultimate goal of developing "on-demand" kidneys for patients in need of transplantation.
Dr. Patel is studying the response of bladder stem cells to partial bladder outlet obstruction in a murine model in Dr. Edward Gong’s lab.
Dr. Yura is working in Dr. Hofer’s lab to study the effects of hormones on urethral homeostasis and regeneration.